Chitosan Hemostatic from byproducts of Atlantic Canadian shellfish. By the tonne.
☑️ Canadian origin. ☑️ Regional production. ☑️ Supply resilience.
Chitosan hemostatic
A biomaterial that provides a high-surface-area framework that outperforms traditional gauze by bypassing natural clotting limitations.
Applications:
| Medical & pharma | Defence & emergency response |
|---|---|
|
|
Why choose chitosan hemostatic?
-
Demonstrate clotting efficiency up to 3.41 times greater than standard sponges.
-
Directly induces erythrocyte agglutination to work effectively even in heparinized or coagulopathic patients.
-
Ensures optimal gas exchange and moisture regulation while acting as a barrier to peripheral contaminants.
-
Cationic amino groups disrupt bacterial cell walls, inhibiting the growth of S. aureus and E. coli.
-
Chitosan acts as a stabilizer to release silver ions safely, avoiding the cellular toxicity of standard dressings.
-
Degrades into harmless amino sugars, accelerating granulation tissue growth and skin re-epithelialization.
Advantages of working with Atlantic BioCorp
Medical-grade precision
High purity with tailored molecular weights engineered for Global Defence and Emergency Response.
Local reliability
Avoid shipping delays and inconsistent quality by partnering with a Canadian-based producer.
Precision under pressure
High purity with tailored molecular weights engineered for Global Defence and Emergency Response.
Sustainability
Align with MSC-certified, sustainable inputs that meet modern environmental standards without compromising performance.
Full traceability
Every batch is mapped from the North Atlantic to your facility, ensuring a secure, sovereign and transparent supply chain.
R&D collaboration
Work with our McGill partners to customize fibre diameter and silver-ion levels for specific field applications.
Explore other products.
Carbonized chitin
Derivatives and nanocrystals
Chitin
Chitosan